Study summary · research use only
[Effectiveness of immunostimulants in nonspecific ulcerative colitis]
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This study examined the clinical and immunologic effects of immunostimulants (levamisole, sodium nucleinate, thymic preparations) used alone and in various combinations in human patients with nonspecific ulcerative colitis. The authors reported that the effects of these agents depended on disease severity, being highest in the light course, with thymalin and sodium nucleinate showing the highest clinical and immunologic effects, particularly when used together. Levamisole administration was associated with frequent side effects and no essential advantage over basic therapy. The authors concluded that immunostimulants are pathogenetically validated in ulcerative colitis therapy, leading to reduction or elimination of immunity insufficiency and a positive clinical outcome in the majority of cases.
Abstract
Clinical and immunologic efficacies of some immunostimulants (levamisole, sodium nucleinate, thymic preparations) included in therapeutic schemes in nonspecific ulcerous colitis both separately and in various combinations were under study. The efficacy of these stimulants was found to depend on the disease severity and proved to be the highest in the light course. Thymalin and sodium nucleinate showed the highest clinical and immunologic efficacies, particularly if used together. Levamisole administration was associated with frequent side effects and had no essential advantages over basic therapy. This permits a conclusion that immunostimulants are pathogenetically validated in therapy of ulcerous colitis, for they result in reduction or elimination of immunity insufficiency and their administration leads to a positive clinical effect in the majority of cases.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.